Projects In Knowledge - Continuing Medical Education (CME)

Latest Programs

Case Study: Focus on Screening and Testing

Dr. Di Bisceglie and Dr. Pan
Chair and Faculty

Gastroenterology Tx Reporter e-Newsletter - Identifying persons with chronic HBV infection enables them to receive treatment and prevent transmission to others. In this case presentation of a man whose parents were born in China, Dr. Calvin Pan takes you through the HBV screening and evaluation process, addressing key issues including whom to screen, what tests to order, and how to interpret test results. This Tx Reporter e-newsletter is the first of four in Advanced Certificate Program V: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities. more »1

Expert Insight Into: Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit from an anti-EGFR Monoclonal Antibody in Wild-Type KRAS Metastatic Colon Cancer

Dr. Saltz
Chair

Oncology Article Review - Dr. Leonard Saltz discusses the results of a recent retrospective study that examined the ability of various elements of the EGFR signaling pathway to predict outcomes in patients with metastatic colorectal cancer treated with an anti-EGFR monoclonal antibody. He also discusses the results from another study that investigated some of these same elements in patients with advanced colorectal cancer treated with chemotherapy. more »2

Expert Insight Into: EGFR Tyrosine Kinase Inhibitor or Combination Chemotherapy in Advanced Pulmonary Adenocarcinoma.
(Part 2 of Series)

Dr. Herbst
Co-Chair

Oncology Article Review - The EGFR tyrosine kinase inhibitor gefitinib has demonstrated significant efficacy in patients with previously treated NSCLC. In this course, Dr. Roy Herbst reviews the findings from a randomized phase III trial that compared single-agent gefitinib versus combination chemotherapy with carboplatin and paclitaxel for the initial treatment of advanced pulmonary adenocarcinoma in selected patients in East Asia. more »3

Expert Insight Into: A Human Epidermal Growth Factor Receptor 2 (HER2)-Specific Monoclonal Antibody Plus an Aromatase Inhibitor (AI) Versus an AI Alone for the Treatment of Postmenopausal Women with HER2–Positive/Hormone Receptor-Positive Metastatic Breast Cancer.

Dr. Gonzalez-Angulo
Faculty

Oncology Article Review - Dr. Ana Maria Gonzalez-Angulo reports on results of the recently published Phase III TAnDEM study, the first clinical trial in postmenopausal women to combine a hormonal agent and trastuzumab without chemotherapy in the treatment of HER2 and hormone receptor copositive metastatic breast cancer. more »4

Case Study: Radiologically Isolated Syndrome—An Emerging Concept

Dr. Miller and Dr. DeAngelis
Co-Chair and Faculty

Neurology Tx Reporter e-Newsletter - Join Dr. Tracy M. DeAngelis as she follows the case of a woman who has MRI findings consistent with multiple sclerosis (MS) yet has no symptoms of the disease. Should she be diagnosed with MS? Should she receive disease-modifying therapy? Find answers to these questions in this case-based activity. more »5

Monitoring

Dr. Lewiecki
Contributing
Editor

Osteoporosis Chapter - Patients may not respond to osteoporosis therapy for a variety of reasons, including poor adherence and undiagnosed secondary medical conditions. Monitoring enables the clinician to identify those patients who are continuing to lose bone mass while on therapy and address the factors compromising response. In this chapter, Dr. E. Michael Lewiecki describes the rationale and specifics of effective monitoring. more »6

Expert Insight Into: Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C

Dr. Kim
Faculty

Gastroenterology Article Review - To gain a better understanding of gaps in the effort to reduce and control HBV and HCV infections and to define steps to correct these problems, the Institute of Medicine (IOM) assessed current prevention and control efforts and identified areas for research, policy change, and collaboration between private and public organizations. Based on this assessment, the IOM has recommended changes in four areas — surveillance, knowledge and awareness, immunization, and services for viral hepatitis. Dr. W. Ray Kim comments on these recommendations and suggests steps that community clinicians can take in their own practices to further the goals outlined in this report. more »7

Expert Insight Into: Use of a Single Magnetic Resonance Imaging Examination to Predict Conversion to Medically Definite Multiple Sclerosis.

Dr. Miller
Faculty

Neurology Article Review - This course discusses a recent study that investigated the use of a single MRI evaluation of the brain obtained early after a clinically isolated syndrome to predict conversion to clinically definite multiple sclerosis. Dr. Aaron Miller comments on the clinical implications of the study findings more »8

Expert Insight Into: Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer (Part 1 of Series)

Dr. Langer
Co-Chair

Oncology Article Review - EGFR gene mutations can produce hypersensitivity to EGFR tyrosine kinase inhibitors in patients with NSCLC, but studies investigating the clinical benefit of this approach in these patients have been lacking. Dr. Corey Langer comments on the findings from a prospective, large-scale study of erlotinib in NSCLC patients with EGFR mutations. more »9

Expert Insight Into: Physical Activity and Male Colorectal Cancer Survival

Dr. Eng
Faculty

Oncology Article Review - Although the protective effects of physical activity on the development of colorectal cancer are well recognized, data on the role of physical activity on outcomes in patients diagnosed with colorectal cancer are limited. In this course, Dr. Cathy Eng reviews the findings of a study that assessed the effects of post-diagnosis leisure-time physical activity on mortality in patients diagnosed with nonmetastatic colorectal cancer. more »10

Browse Home » Gastroenterology » Hematology » Infectious Diseases » Neurology » Oncology » Osteoporosis » Psychiatry » Women's Health » Keep up to date with us via twitter! Latest News powered by:	Latest Programs Case Study: Focus on Screening and Testing Dr. Di Bisceglie and Dr. Pan Chair and Faculty Gastroenterology Tx Reporter e-Newsletter - Identifying persons with chronic HBV infection enables them to receive treatment and prevent transmission to others. In this case presentation of a man whose parents were born in China, Dr. Calvin Pan takes you through the HBV screening and evaluation process, addressing key issues including whom to screen, what tests to order, and how to interpret test results. This Tx Reporter e-newsletter is the first of four in Advanced Certificate Program V: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities. more »1 Expert Insight Into: Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit from an anti-EGFR Monoclonal Antibody in Wild-Type KRAS Metastatic Colon Cancer Dr. Saltz Chair Oncology Article Review - Dr. Leonard Saltz discusses the results of a recent retrospective study that examined the ability of various elements of the EGFR signaling pathway to predict outcomes in patients with metastatic colorectal cancer treated with an anti-EGFR monoclonal antibody. He also discusses the results from another study that investigated some of these same elements in patients with advanced colorectal cancer treated with chemotherapy. more »2 Expert Insight Into: EGFR Tyrosine Kinase Inhibitor or Combination Chemotherapy in Advanced Pulmonary Adenocarcinoma. (Part 2 of Series) Dr. Herbst Co-Chair Oncology Article Review - The EGFR tyrosine kinase inhibitor gefitinib has demonstrated significant efficacy in patients with previously treated NSCLC. In this course, Dr. Roy Herbst reviews the findings from a randomized phase III trial that compared single-agent gefitinib versus combination chemotherapy with carboplatin and paclitaxel for the initial treatment of advanced pulmonary adenocarcinoma in selected patients in East Asia. more »3 Expert Insight Into: A Human Epidermal Growth Factor Receptor 2 (HER2)-Specific Monoclonal Antibody Plus an Aromatase Inhibitor (AI) Versus an AI Alone for the Treatment of Postmenopausal Women with HER2–Positive/Hormone Receptor-Positive Metastatic Breast Cancer. Dr. Gonzalez-Angulo Faculty Oncology Article Review - Dr. Ana Maria Gonzalez-Angulo reports on results of the recently published Phase III TAnDEM study, the first clinical trial in postmenopausal women to combine a hormonal agent and trastuzumab without chemotherapy in the treatment of HER2 and hormone receptor copositive metastatic breast cancer. more »4 Case Study: Radiologically Isolated Syndrome—An Emerging Concept Dr. Miller and Dr. DeAngelis Co-Chair and Faculty Neurology Tx Reporter e-Newsletter - Join Dr. Tracy M. DeAngelis as she follows the case of a woman who has MRI findings consistent with multiple sclerosis (MS) yet has no symptoms of the disease. Should she be diagnosed with MS? Should she receive disease-modifying therapy? Find answers to these questions in this case-based activity. more »5 Monitoring Dr. Lewiecki Contributing Editor Osteoporosis Chapter - Patients may not respond to osteoporosis therapy for a variety of reasons, including poor adherence and undiagnosed secondary medical conditions. Monitoring enables the clinician to identify those patients who are continuing to lose bone mass while on therapy and address the factors compromising response. In this chapter, Dr. E. Michael Lewiecki describes the rationale and specifics of effective monitoring. more »6 Expert Insight Into: Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C Dr. Kim Faculty Gastroenterology Article Review - To gain a better understanding of gaps in the effort to reduce and control HBV and HCV infections and to define steps to correct these problems, the Institute of Medicine (IOM) assessed current prevention and control efforts and identified areas for research, policy change, and collaboration between private and public organizations. Based on this assessment, the IOM has recommended changes in four areas — surveillance, knowledge and awareness, immunization, and services for viral hepatitis. Dr. W. Ray Kim comments on these recommendations and suggests steps that community clinicians can take in their own practices to further the goals outlined in this report. more »7 Expert Insight Into: Use of a Single Magnetic Resonance Imaging Examination to Predict Conversion to Medically Definite Multiple Sclerosis. Dr. Miller Faculty Neurology Article Review - This course discusses a recent study that investigated the use of a single MRI evaluation of the brain obtained early after a clinically isolated syndrome to predict conversion to clinically definite multiple sclerosis. Dr. Aaron Miller comments on the clinical implications of the study findings more »8 Expert Insight Into: Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer (Part 1 of Series) Dr. Langer Co-Chair Oncology Article Review - EGFR gene mutations can produce hypersensitivity to EGFR tyrosine kinase inhibitors in patients with NSCLC, but studies investigating the clinical benefit of this approach in these patients have been lacking. Dr. Corey Langer comments on the findings from a prospective, large-scale study of erlotinib in NSCLC patients with EGFR mutations. more »9 Expert Insight Into: Physical Activity and Male Colorectal Cancer Survival Dr. Eng Faculty Oncology Article Review - Although the protective effects of physical activity on the development of colorectal cancer are well recognized, data on the role of physical activity on outcomes in patients diagnosed with colorectal cancer are limited. In this course, Dr. Cathy Eng reviews the findings of a study that assessed the effects of post-diagnosis leisure-time physical activity on mortality in patients diagnosed with nonmetastatic colorectal cancer. more »10	Featured Programs Multiple Sclerosis Resource Network Northwest Region *Join Now!* Social Media, HCV and the Gastroenterologist CME/CE Symposium New Orleans • May 2, 2010 Living Medical Textbook Neurology Parkinson's Disease Edition Coming Soon! Advanced Certificate Program V Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities *New 2010 Program* Lung Cancer Management III Osteoporosis: A Focus on Fracture Prevention On-Demand Webcast, Available 24/7 Watch It Now Game Changers in Hepatology— Future Challenges in the Treatment of HCV Projects In Knowledge poster presented at 2009 Breast Cancer Symposium Survey Findings: Breast Cancer Management by Nurses *Read more...* Update on Osteoporosis for the Rheumatologist On-Demand Webcast Zeroing in on Non-Small Cell Lung Cancer: Integrating Targeted Therapies into Practice On-Demand Webcast The Advanced Certificate Program: Multiple Sclerosis Management I & II Breast Cancer Management II Management of Stage III, N2 NSCLC: Virtual Thoracic Oncology Tumor Board Go to Activity Profiles in CML: Case-Based Approaches to Managing Resistance and Improving Outcomes *Webcast* Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities	Recognizing and Treating Multiple Sclerosis in Primary Care Live Free CME/CE Lectures & Workshops *Register Now!* Saturday, March 27, 2010 Portland, Oregon Saturday, April 24, 2010 Seattle, Washington Saturday, May 15, 2010 Boise, Idaho Controversies in Targeted Therapy: Management of Recurrent Ovarian Cancer Coming Soon! Living Medical Textbook Neurology Multiple Sclerosis Edition Experts Responding to Your Questions: Video Q&A *A Quarterly Online CME/CE activity* Living Medical Textbook Hematology Insights into Managing Leukemia Edition The Advanced Certificate Program Hepatocellular Carcinoma Special Announcement Projects In Knowledge poster presented at DDW 2009 Survey Findings: HBV Management Among U.S. Clinicians *Read more...* The Certificate Program in Advanced/Metastatic Colorectal Cancer Living Medical Textbook Osteoporosis Fracture Prevention and Therapeutic Management Edition Osteoporosis Compendium A Sea Change in MS Treatment— The Potential of Small Molecules On-Demand Interactive Webcast The Advanced Certificate Program: Lung Cancer Management II